Brian McCullough
Psychiatric/Mental Health · Phoenix, AZNPI 1780208959
Payments from drug & device makers
Across 239 payments — averaging $16.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$846
- AbbVie$705
- Corium, LLC$427
- Otsuka America Pharmaceutical, Inc.$308
- Lundbeck LLC$276
- Tris Pharma Inc$272
- plus $1K from 14 others
What the payments were for
- Food & beverage$3,83199%
- Education$471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 57 | $846 |
| AbbVie(2 entities) | 44 | $705 |
| Corium, LLC | 33 | $427 |
| Otsuka America Pharmaceutical, Inc. | 13 | $308 |
| Lundbeck LLC | 17 | $276 |
| Tris Pharma Inc | 15 | $272 |
| Vanda Pharmaceuticals Inc. | 8 | $143 |
| Alkermes, Inc. | 8 | $140 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $140 |
| Neurocrine Biosciences, Inc. | 7 | $117 |
| Supernus Pharmaceuticals, Inc. | 6 | $107 |
| Axsome Therapeutics, Inc. | 5 | $93 |
| Johnson & Johnson | 3 | $59 |
| Ironshore Pharmaceuticals Inc. | 4 | $58 |
| Neos Therapeutics, LP | 3 | $52 |
| Vertical Pharmaceuticals, LLC | 2 | $38 |
| Noven Therapeutics, LLC | 2 | $37 |
| E.r. Squibb & Sons, L.L.C. | 2 | $32 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Almatica Pharma LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,878 in reported general payments places this provider in the 90th percentile of 1,230 psychiatric/mental health providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 13 | $696 |
| Aripiprazole | 12 | $278 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 12 | $276 |
| Eszopiclone | 27 | $167 |
| Clonazepam | 18 | $76 |
| Gabapentin | 11 | $60 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Phoenix
- Elizabeth ElliottPhoenix$363K
- Russell HorningPhoenix$254K
- Claire ReecePhoenix$88K
- Luis FongPhoenix$59K
- Marilizabeth BirkPhoenix$34K
- Jaime LecomtePhoenix$15K
- Roger MayorgaPhoenix$10K
- Elena SassPhoenix$9K
- Martha SerranoPhoenix$8K
- Bonnie VogesPhoenix$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.